Once the IV is in place, the magic begins
Rosenberger A, Illig T, Korb K, Klopp N, Zietemann V, Wlke G, et al
In clinical trials, the most common observations were gastrointestinal effects: nausea (44.2% vs 17.4% placebo in STEP 1), diarrhea (30.0%), vomiting (24.8%), and constipation (24.2%)
Prof Ralf Ludwig, lead author of the study, commented: Our findings suggest that GLP-1 RAs may offer benefits beyond their effects on weight and glucose control, particularly for cardiovascular and psychiatric outcomes in people with psoriasis
Depending on your needs, your program may include GLP-1 weight loss medications such as semaglutide or tirzepatide, prescription-based weight management, hormone replacement therapy (HRT), testosterone optimization (TRT), advanced diagnostic testing, and structured nutrition support
Neuroprotekcyjne dziaanie BPC-157 Powyej przedstawione badania pozwalaj na zakwalifikowanie peptydu BPC-157, zarwno w formie doustnej jak i formie iniekcyjnej, jako preparatu dziaajcego neuroprotekcyjnie